These maps show the percentage coverage of the third dose of Hib vaccine worldwide from 1998 to 2007 in children <1year of age.
这组地图显示由一九九八至二零零七年一岁以下儿童乙型流感嗜血杆菌第三剂接种的全球覆盖率。
The World Health Organization (WHO), recognizing these obstacles, recommends Hib vaccine "where resources permit its use and the burden of disease is established".
世界卫生组织认识到这些障碍，建议“在资源许可和已确定疾病负担的地方”使用Hib疫苗。
The GIVS also incorporates the GAVI goal of "50% of the poorest countries with high disease burdens and adequate delivery systems will have introduced Hib vaccine by 2005".
全球免疫理想和战略还采用了疫苗和免疫全球联盟的目标，即“到2005年在50%的具有较高疾病负担和适当供应系统的最贫穷国家引进Hib疫苗”。
There is substantial regional variability in vaccine use, and the study suggests that expanded use of Hib vaccines could have considerable benefit in reducing child mortality worldwide.
疫苗的使用在不同的地区产生显著的变化，研究指出Hbi疫苗的广泛使用可是儿童死亡率有显著的降低。
Resistance of Hib to several of the more inexpensive but effective antibiotics is a growing cause of concern and provides additional impetus for expanding vaccine coverage.
Hib对许多价格较低廉但有效的抗生素的耐药性造成日益增长的关注，并为扩大疫苗覆盖面提供了额外的推动力。
Resistance of Hib to several of the more inexpensive but effective antibiotics is a growing cause of concern and provides additional impetus for expanding vaccine coverage.
Hib对许多价格较低廉但有效的抗生素的耐药性造成日益增长的关注，并为扩大疫苗覆盖面提供了额外的推动力。
应用推荐